Foamex commences rights offering and reduces debt by $100 million
Foamex International Inc has commenced its previously announced rights offering, as well as a second lien loan offering, and has reduced debt by $100 million, the company announced 25 June.
Aeolus Pharmaceuticals, Inc. announced today that it completed a $1.5 million financing with two existing institutional shareholders, both of which are affiliates of Xmark Opportunity Partners, LLC. Under the terms of the financing agreement, Aeolus received $1.5 million in gross proceeds in exchange for 5,357,143 shares of Aeolus Pharmaceuticals common stock, and 5 year warrants to